Literature DB >> 12562011

Pharmacological activities of Genistein, an isoflavone from soy (Glycine max): part I--anti-cancer activity.

A C Suthar1, M M Banavalikar, M K Biyani.   

Abstract

Phytoestrogens represent a family of plant compounds such as isoflavones, flavones and lignans. A variety of these plant compounds have been identified in various human body fluids. A wide range of commonly consumed foods contains appreciable amounts of these different phytoestrogens, viz. soy products are particularly good sources of isoflavones and lignans. Accumulating evidences from molecular and cellular biology experiments, animal studies, and to a limited extent, human clinical trials suggests that phytoestrogens may potentially confer health benefits related to various cancers and diseases such as cardiovascular disorder. The evidences reviewed here represent the beneficial effects of most potential and promising isoflavone, Genistein in various types of cancers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12562011

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  4 in total

1.  Genistein inhibits invasive potential of human hepatocellular carcinoma by altering cell cycle, apoptosis, and angiogenesis.

Authors:  Yan Gu; Chen-Fang Zhu; Hitoshi Iwamoto; Ji-Sheng Chen
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

2.  Inhibitory Effect of Genistein on PLC/PRF5 Hepatocellular Carcinoma Cell Line.

Authors:  Mehdi Nikbakht Dastjerdi; Fraidoon Kavoosi; Ali Valiani; Ebrahim Esfandiari; Masume Sanaei; Saeed Sobhanian; Mazdak Ganjalikhani Hakemi; Maryam Mobarakian
Journal:  Int J Prev Med       Date:  2015-06-17

Review 3.  Pea, Pisum sativum, and Its Anticancer Activity.

Authors:  Runchana Rungruangmaitree; Wannee Jiraungkoorskul
Journal:  Pharmacogn Rev       Date:  2017 Jan-Jun

Review 4.  The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research.

Authors:  Na Song; Kai Cui; Ke Zhang; Jie Yang; Jia Liu; Zhuang Miao; Feiyue Zhao; Hongjing Meng; Lu Chen; Chong Chen; Yushan Li; Minglong Shao; Jinghang Zhang; Haijun Wang
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.